Clinical Data Misuse Claims

1. Meaning of Clinical Data Misuse

Clinical Data Misuse Claims arise when health-related information collected in the course of patient care, clinical research, diagnosis, treatment, medical testing, or healthcare administration is accessed, disclosed, transferred, sold, analyzed, repurposed, or otherwise used in a manner that exceeds the lawful or authorized purpose for which it was collected.

Clinical data can include:

• electronic health records (EHRs);
• laboratory results;
• diagnostic images;
• genetic information;
• prescription histories;
• treatment records;
• clinical-trial information;
• genomic data;
• biometric health information;
• mental-health records;
• reproductive-health information;
• HIV/AIDS information;
• patient-identification information;
• de-identified or pseudonymized datasets;
• data generated by medical devices;
• AI-generated clinical datasets.

A misuse claim can therefore arise even where there is no physical injury. The injury may consist of an unlawful disclosure, invasion of privacy, breach of confidentiality, unauthorized commercialization, violation of an agreement, discrimination, or misuse of information for a secondary purpose.

A particularly important modern issue is whether information described as “de-identified” remains sufficiently connected to individuals to create legal liability. Dinerstein v. Google is a leading illustration of this problem.

2. Clinical Data Misuse vs Ordinary Medical Negligence

These concepts should not be confused.

Medical negligence

Usually concerns:

How the patient was treated.

Example:

A doctor negligently performs surgery.

Clinical data misuse

Concerns:

How information about the patient was handled.

Example:

A hospital transfers patient records to a technology company for AI development without adequate authorization or in breach of applicable restrictions.

Thus:

Medical negligence = treatment-related harm

Clinical data misuse = information-related harm

The two can, however, occur simultaneously.

3. Common Forms of Clinical Data Misuse

A. Unauthorized Disclosure

A hospital employee provides medical records to an unauthorized third party.

B. Secondary Use Without Proper Authorization

Data collected for treatment is subsequently used for:

• commercial research;
• advertising;
• AI training;
• pharmaceutical marketing;
• product development;
• insurance analytics.

C. Sale or Commercialization

Clinical information is transferred for financial benefit without a sufficient legal basis.

D. Re-identification

A supposedly anonymous dataset is combined with other information to identify patients.

E. Excessive Internal Access

Employees access records unrelated to their professional duties.

F. Research Misuse

Clinical data collected for one research project is reused for another project without satisfying applicable consent, authorization, institutional-review or privacy requirements.

G. AI and Machine-Learning Misuse

Hospitals may provide large datasets to technology companies to train algorithms.

Potential disputes include:

• whether patients consented;
• whether data was genuinely de-identified;
• whether contractual restrictions were followed;
• whether re-identification was attempted;
• whether data was used beyond the agreed research purpose.

H. Genetic and Genomic Data Misuse

Genetic data is particularly sensitive because it can reveal information about:

• disease susceptibility;
• family relationships;
• ancestry;
• future health risks.

Misuse can therefore produce privacy, discrimination and autonomy claims.

4. Legal Foundations of Clinical Data Misuse Claims

Depending on the jurisdiction, claims may arise under several bodies of law.

1. Privacy law

Protects individuals against unauthorized collection, disclosure and use.

2. Confidentiality law

Creates duties arising from the doctor-patient or healthcare-provider relationship.

3. Contract law

Privacy notices, patient agreements, research agreements and institutional policies may create enforceable obligations.

4. Tort law

Possible causes include:

• intrusion upon seclusion;
• breach of confidentiality;
• negligence;
• negligent disclosure;
• breach of fiduciary duty.

5. Consumer-protection law

Misleading privacy representations may create liability.

6. Statutory health-data law

In the United States, HIPAA is particularly important, although HIPAA generally does not itself create a private federal damages action for individual patients.

7. Constitutional privacy

In appropriate circumstances, governmental collection or disclosure of medical information can raise constitutional issues.

8. Research regulation

Clinical research may additionally involve:

• informed consent;
• Institutional Review Board requirements;
• Common Rule requirements;
• FDA-related obligations;
• data-use agreements.

5. Essential Elements of a Clinical Data Misuse Claim

A claimant will generally need to establish some combination of the following.

Element 1 — Protected information

The information must fall within a protected category or be subject to a legal duty.

Examples:

• medical records;
• diagnosis;
• treatment history;
• genetic data.

Element 2 — Defendant's possession or control

The defendant must have obtained, stored, processed, disclosed or otherwise controlled the information.

Element 3 — Unauthorized or improper conduct

Examples:

• disclosure without authorization;
• use beyond the permitted purpose;
• sale;
• re-identification;
• excessive access;
• breach of contractual restrictions.

Element 4 — Applicable legal duty

The claimant must identify the source of the duty:

• statute;
• contract;
• confidentiality relationship;
• common law;
• constitutional protection;
• professional duty.

Element 5 — Injury

Potential injury includes:

• financial loss;
• emotional distress;
• privacy invasion;
• reputational injury;
• discrimination;
• loss of autonomy;
• increased risk of identity exposure.

Element 6 — Causation

The claimant must connect the defendant's conduct with the alleged injury where the cause of action requires actual harm.

6. Important Case Laws

1. Dinerstein v. Google LLC, 2023

U.S. Court of Appeals for the Seventh Circuit

This is one of the most directly relevant modern cases.

Facts

The University of Chicago Medical Center and Google entered into a research collaboration to develop machine-learning tools capable of predicting patients' future healthcare needs.

The University provided Google with years of anonymized patient medical records to train the algorithms.

A patient, Matt Dinerstein, brought claims on behalf of himself and other patients whose medical information had been disclosed.

Legal issue

The case raised questions about:

• patient privacy;
• de-identification;
• contractual obligations;
• secondary use of medical information;
• research use;
• class-action claims.

Holding

The Seventh Circuit rejected the plaintiff's contract-based theory.

The court emphasized the terms of the relevant documents and the absence of an enforceable contractual promise of the kind asserted by the plaintiff.

Importance

The case demonstrates that:

The fact that medical data has been transferred to a technology company does not automatically establish liability.

The claimant must identify a legally enforceable duty and show that the defendant violated it.

Major lesson

De-identification + contractual language + purpose of data use can be decisive.

7. Dinerstein v. Google — District Court Proceedings

The earlier district-court decision is independently important.

The University had disclosed “de-identified” electronic health records of adult patients treated between 2010 and 2016 to Google for research purposes.

The plaintiff asserted several state-law theories.

The district court dismissed the claims, including because the plaintiff had not established the necessary legal basis for relief.

Significance

The case demonstrates that courts distinguish between:

data that identifies a patient

and

data that has been legally de-identified.

However, de-identification does not mean that every subsequent use is automatically lawful. The precise data-use agreement, privacy representations and applicable state law remain important.

8. Sorrell v. IMS Health Inc., 564 U.S. 552 (2011)

U.S. Supreme Court

Facts

Pharmacies collected prescription information containing information about physicians' prescribing practices.

Data-mining companies obtained the information and generated reports for pharmaceutical companies to improve drug marketing.

Vermont enacted legislation restricting the sale, disclosure and use of prescriber-identifying information for marketing purposes.

Holding

The Supreme Court struck down Vermont's restrictions under the First Amendment.

The Court treated the regulation as a restriction on protected speech and applied heightened scrutiny.

Importance for clinical-data misuse

Sorrell is unusual because the Court did not decide the case primarily as a medical-privacy case.

Instead, it demonstrates that:

Government regulation of health-information use can collide with constitutional protection for information and commercial speech.

Lesson

Clinical data regulation must sometimes balance:

• privacy;
• public health;
• commercial interests;
• information access;
• constitutional rights.

The case is particularly relevant to pharmaceutical marketing and prescription-data analytics.

9. Norman-Bloodsaw v. Lawrence Berkeley Laboratory, 135 F.3d 1260 (9th Cir. 1998)

Facts

Employees at Lawrence Berkeley Laboratory underwent medical examinations.

The plaintiffs alleged that blood and medical information was collected and tested for purposes that were not adequately disclosed or authorized.

The testing included sensitive information concerning:

• sickle-cell trait;
• syphilis;
• pregnancy.

Holding

The Ninth Circuit recognized that unauthorized collection and testing of highly personal medical information could implicate constitutional privacy interests.

Principle

Medical information can fall within the constitutionally protected sphere of personal privacy.

Importance

The case is highly relevant to clinical-data misuse because it demonstrates that the problem is not limited to disclosure.

Misuse may begin at the stage of:

collection + testing + analysis.

Therefore:

Unauthorized medical-data processing itself may be actionable in appropriate circumstances.

10. Doe v. Medlantic Health Care Group, Inc., 814 A.2d 939 (D.C. 2003)

Facts

The case concerned disclosure of highly sensitive medical information.

The dispute involved allegations concerning unauthorized disclosure and the resulting invasion of privacy.

Principle

Medical information carries a special expectation of confidentiality, particularly when the information concerns highly sensitive conditions.

Importance

The case demonstrates the potential role of common-law privacy and confidentiality principles even apart from federal health-information statutes.

It illustrates an important proposition:

A healthcare provider's duty may arise from the confidential physician-patient relationship itself.

Thus, the absence of a direct federal private cause of action under HIPAA does not necessarily eliminate all possible state-law remedies.

11. Byrne v. Avery Center for Obstetrics & Gynecology, P.C., 102 A.3d 32 (Conn. 2014)

Facts

A patient had provided medical information to her healthcare provider.

A third party subsequently sought access to information through legal proceedings.

The patient alleged that disclosure of her medical information violated confidentiality obligations and created serious personal consequences.

Holding

The Connecticut Supreme Court recognized that a patient could pursue a common-law negligence claim against a healthcare provider for improper disclosure of confidential medical information.

Importance

The case is particularly significant because it demonstrates that:

Confidentiality duties can exist independently of HIPAA.

Therefore, a healthcare institution cannot necessarily defend every disclosure claim merely by arguing that HIPAA does not create a private cause of action.

12. Acosta v. Byrum, 638 S.E.2d 246 (N.C. 2006)

Facts

A psychiatrist's employee allegedly obtained and disclosed confidential patient information.

The dispute concerned whether the disclosure could support liability under state law.

Holding

The North Carolina Supreme Court allowed claims based upon misuse of confidential medical information to proceed under state-law theories.

Importance

The case demonstrates that:

• confidentiality relationships matter;
• unauthorized access by healthcare personnel can create liability;
• state tort law may supplement federal privacy regulation.

13. Doe v. University of Michigan, 2019-era litigation concerning medical-record privacy

Medical-record cases involving universities and healthcare institutions have repeatedly demonstrated that courts analyze the specific source of confidentiality, the institution's policies, and the nature of the alleged disclosure rather than treating every medical-data incident as automatically actionable.

Principle

The claimant should identify:

1. what information was disclosed;
2. who accessed it;
3. why it was accessed;
4. what authorization existed;
5. what legal duty prohibited the conduct;
6. what injury resulted.

This analytical structure is increasingly important with large institutional databases.

14. Comparative Indian Perspective

India has a developing framework for clinical-data misuse claims.

The most important constitutional foundation is privacy as a fundamental right.

Justice K.S. Puttaswamy (Retd.) v. Union of India, (2017) 10 SCC 1

Supreme Court of India

The nine-judge Constitution Bench recognized privacy as a constitutionally protected fundamental right under Article 21 and other freedoms guaranteed by Part III.

Clinical-data significance

Medical information is among the most intimate forms of personal information.

Accordingly, unauthorized collection, disclosure or processing of clinical information can potentially implicate:

• informational privacy;
• bodily privacy;
• decisional autonomy;
• dignity;
• personal liberty.

Key principle

The state or other legally regulated actors cannot treat personal information as completely devoid of constitutional significance.

15. Clinical Data and Informational Privacy

The concept of informational privacy is particularly important.

It concerns a person's ability to exercise some control over:

• what information is collected;
• who receives it;
• why it is used;
• how long it is retained;
• whether it is shared;
• whether it is combined with other information.

Clinical data is especially sensitive because it can reveal information that a person may never wish to disclose publicly.

Examples include:

• cancer diagnosis;
• HIV status;
• infertility;
• pregnancy;
• mental-health treatment;
• genetic disease;
• reproductive-health decisions.

16. Clinical Data Misuse in Artificial Intelligence

AI creates a new category of clinical-data disputes.

Suppose:

Hospital

↓

collects patient records

↓

Research agreement

↓

shares records with technology company

↓

AI training

↓

algorithm developed

↓

Commercial deployment

A patient may ask:

Was my information authorized for this entire chain of uses?

This creates several legal questions.

A. Purpose limitation

Was the data used only for the purpose for which it was collected?

B. Consent

Did the patient consent to AI-related secondary use?

C. De-identification

Can individuals realistically be re-identified?

D. Contract

Did the hospital promise to restrict use?

E. Commercialization

Did a private company obtain an economic benefit?

F. Data governance

Were appropriate security and access controls used?

The Dinerstein litigation is particularly important because it demonstrates how these questions arise when hospitals transfer de-identified EHR datasets to technology companies for machine-learning research.

17. De-identified Data Is Not Necessarily Risk-Free

There are three broad categories:

Identified data

Directly identifies the patient.

Example:

Name + medical record number + diagnosis.

Pseudonymized data

Direct identifiers are replaced but a key exists.

Example:

Patient 47291 + diagnosis.

De-identified/anonymized data

Identifiers have been removed according to the applicable legal standard.

However, modern data analytics can sometimes create re-identification risks by combining multiple datasets.

For example:

age + rare disease + hospital + treatment date + geographic information

may make an individual identifiable even without a name.

Therefore:

De-identification is a legal and technical process, not merely deletion of the patient's name.

18. Clinical Data Misuse and HIPAA

HIPAA is extremely important in the United States.

The Privacy Rule generally regulates covered entities and business associates concerning protected health information.

It establishes requirements concerning:

• permitted uses;
• disclosures;
• authorization;
• minimum necessary information;
• research;
• public-health uses;
• patient rights;
• security.

But there is an important litigation point:

HIPAA generally does not provide an individual with a private federal cause of action for damages.

Therefore, a patient may need to rely upon:

• state privacy law;
• negligence;
• breach of contract;
• breach of confidentiality;
• consumer-protection law;
• constitutional claims where applicable.

This is why cases such as Byrne and Dinerstein are important.

19. Clinical Research Data Misuse

Clinical research creates a difficult balance.

Society benefits from using clinical data to:

• discover new drugs;
• identify disease patterns;
• improve diagnosis;
• develop AI;
• monitor adverse effects;
• conduct epidemiological research.

But research subjects also possess interests in:

• autonomy;
• confidentiality;
• informed consent;
• privacy;
• control over secondary uses.

Therefore, lawful research-data governance generally requires attention to:

1. Informed consent

Was the subject informed adequately?

2. Scope

What research was authorized?

3. Secondary use

Can the information be used for another study?

4. De-identification

Has the data been adequately de-identified?

5. Institutional oversight

Was appropriate ethics/IRB review obtained?

20. Commercial Exploitation of Clinical Data

A particularly controversial form of misuse occurs when patient data becomes a commercial asset.

For example:

Patients provide data → hospital collects data → company obtains dataset → company develops commercial AI → company earns revenue.

The legal questions include:

• Did patients authorize commercial use?
• Did the hospital have authority to transfer the information?
• Was the data properly de-identified?
• Was there a data-use agreement?
• Did the institution make representations about privacy?
• Did the company comply with restrictions?
• Did commercialization exceed the original purpose?

The law does not universally recognize a patient's property right in every piece of medical data, so a claimant generally needs to identify a more specific legal right or duty.

21. Possible Remedies

Depending upon jurisdiction and cause of action, remedies may include:

Injunction

Stopping further use or disclosure.

Deletion

Requiring improperly obtained information to be deleted.

Damages

For legally recognized injury.

Emotional-distress damages

Where recognized by applicable tort law.

Statutory damages

Where a statute provides them.

Punitive damages

For sufficiently egregious misconduct under applicable law.

Declaratory relief

Court declaration that the defendant's conduct was unlawful.

Corrective measures

Such as:

• improved access controls;
• employee training;
• audit mechanisms;
• data-governance programs.

22. Class Actions

Clinical-data misuse is particularly suitable for class-action litigation when:

• thousands of patients are affected;
• the same database was used;
• the same disclosure occurred;
• the same privacy policy applies;
• common questions predominate.

A typical class might consist of:

“All patients whose medical records were transferred to Defendant X without the legally required authorization.”

However, class certification can become difficult when:

• patients gave different consents;
• different records were disclosed;
• different state laws apply;
• some patients suffered actual harm while others did not.

The Dinerstein litigation illustrates the relationship between medical-data disclosure and class-action procedure.

23. Important Distinctions

24. Key Case-Law Principles

The leading cases can be remembered as follows:

Dinerstein v. Google

De-identified clinical data + AI research + contract/privacy claims

Sorrell v. IMS Health

Prescription data + commercialization + constitutional free speech

Norman-Bloodsaw

Unauthorized collection/testing of sensitive medical information + privacy

Doe v. Medlantic

Medical confidentiality + privacy tort principles

Byrne v. Avery Center

Healthcare-provider confidentiality can support state-law liability independently of HIPAA

Acosta v. Byrum

Unauthorized disclosure/misuse of medical information + state tort liability

Puttaswamy

Informational privacy + dignity + constitutional protection in India

25. Emerging Issues

A. Generative AI

Hospitals may use clinical records to train:

• diagnostic models;
• language models;
• clinical decision-support systems.

The major issue will be whether historical patient data can lawfully be reused for such purposes.

B. Data Brokers

Health-related information can potentially be aggregated from:

• pharmacies;
• hospitals;
• apps;
• wearable devices;
• insurance records.

The combination may create detailed individual health profiles.

C. Genetic Data

Genomic datasets raise special concerns because data concerning one person can reveal information about relatives.

D. Reproductive Health Data

After major changes in U.S. reproductive-health law, disclosure of reproductive-health information can create particularly serious privacy and legal consequences.

E. Wearable and Remote-Patient Data

Modern healthcare produces information outside hospitals:

• smartwatches;
• glucose monitors;
• fitness devices;
• remote cardiac monitors;
• home diagnostic systems.

Whether traditional medical-privacy rules cover all such information is an increasingly important question.

26. Practical Structure of a Clinical Data Misuse Claim

A well-developed claim can be structured as:

1. Identify the data

↓

2. Establish its sensitivity

↓

3. Identify how defendant obtained it

↓

4. Identify original purpose

↓

5. Identify subsequent use

↓

6. Determine authorization/consent

↓

7. Identify applicable legal duty

↓

8. Establish unauthorized conduct

↓

9. Prove injury

↓

10. Establish causation

↓

11. Select remedy

This framework is particularly useful in clinical-AI disputes.

27. Conclusion

Clinical Data Misuse Claims sit at the intersection of medical confidentiality, privacy law, tort law, contract law, healthcare regulation, research ethics and emerging AI governance.

The most important legal principle is that possession of clinical data does not necessarily mean unrestricted authority to use that data for any purpose. The legality of a particular use depends on the source of the data, consent, applicable privacy legislation, confidentiality duties, contractual restrictions, de-identification, purpose of processing and the nature of the alleged injury.

The cases establish several complementary principles:

• Dinerstein v. Google demonstrates the difficulty of using allegedly de-identified patient records for AI research and the importance of contractual and privacy obligations. 
• Sorrell v. IMS Health demonstrates the constitutional complications surrounding commercial use of health-related information. 
• Norman-Bloodsaw recognizes the significance of privacy in the collection and testing of sensitive medical information.
• Byrne v. Avery Center shows that healthcare confidentiality can generate state-law liability independently of HIPAA.
• Acosta v. Byrum illustrates potential state-law liability for unauthorized medical-information disclosure.
• Puttaswamy provides the Indian constitutional foundation for informational privacy, dignity and autonomy.

Thus, the modern legal approach can be summarized as:

Clinical data may be used for legitimate healthcare and research purposes, but secondary use, disclosure, commercialization, AI training or re-identification must remain within the boundaries established by consent, confidentiality, privacy law, contractual obligations and applicable constitutional or statutory protections.